Trastuzumab in Early-Stage Breast Cancer : The Question of Treatment Timing
Funding a Clinical Trial : The Perspective of a Medicines Funder
Unrelated Medical Costs in Life-Years Gained : Should They be Included in Economic Evaluations of Healthcare Interventions?
Quality-of-Life Assessment in Rheumatoid Arthritis
Multiple Sclerosis in the UK : Service Use, Costs, Quality of Life and Disability
Costs and Effects of Secondary Prevention with Perindopril in Stable Coronary Heart Disease in Poland : An Analysis of the EUROPA Study Including 1251 Polish Patients
Long-Term Cost-Effectiveness Analysis of Nebivolol Compared with Standard Care in Elderly Patients with Heart Failure : An Individual Patient-Based Simulation Model
Assessing the Value of a Future Study
The Authors’ Reply